RET and multiple endocrine neoplasia type 2A: Although most MTC are sporadic, 25% are familial with germline mutations of the RET proto-oncogene resulting in multiple endocrine neoplasia (MEN) type 2A, type 2B, or familial medullary thyroid cancer (FMTC) with a phenotype-genotype correlation [19].